Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy.
about
Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGFBone marrow-derived mesenchymal stem cell-secreted IL-8 promotes the angiogenesis and growth of colorectal cancer.Cancer-associated oxidoreductase ERO1-α drives the production of VEGF via oxidative protein folding and regulating the mRNA level.VEGFR2 targeted antibody fused with MICA stimulates NKG2D mediated immunosurveillance and exhibits potent anti-tumor activity against breast cancerCD24 promoted cancer cell angiogenesis via Hsp90-mediated STAT3/VEGF signaling pathway in colorectal cancer.The roles of microRNA-34b-5p in angiogenesis of thyroid carcinoma.Pre-metastatic niches: organ-specific homes for metastases.TNFAIP8 overexpression: a potential predictor of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor Lewis esophagectomy.Role of AMPK signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma.Identification of Novel FAM134B (JK1) Mutations in Oesophageal Squamous Cell Carcinoma.Advances in studies of tyrosine kinase inhibitors and their acquired resistance.Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma.
P2860
Q33888946-14539FB7-41D4-4130-A399-6E718FEDA176Q33906023-0CEDEFA4-1202-46C8-B916-75E342F80F15Q36619033-EA9E254E-75F4-4C5B-98CC-70D20209ED85Q36964306-B2C1E855-FDE3-4C78-8F95-6802FB50015FQ37086056-D27F0C97-4275-4AC1-8B1A-A81D6631CA2AQ37688297-AADCAAA4-92E1-4843-B763-1806C98866B1Q38694209-FABBDD8B-57B7-4934-826D-BFA73FADCF9DQ38743711-F542EB5E-1A56-4B19-B5DF-134C55B9B1FDQ38793474-BB0B4E05-D5F2-42F1-BA13-FD6D99AE814DQ38819571-FFEF146F-87F5-40E3-BE01-B20FAF7D0C6BQ42276963-CD2572F2-A15C-49AF-8FFC-738BBE70FDAFQ49887903-850BA757-53CA-4B4C-A498-7A628B2614E8Q49887971-EA57E393-4388-496F-8A93-8C7ED3AD1F74
P2860
Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Targeting VEGFR1- and VEGFR2-e ...... for esophageal cancer therapy.
@ast
Targeting VEGFR1- and VEGFR2-e ...... for esophageal cancer therapy.
@en
type
label
Targeting VEGFR1- and VEGFR2-e ...... for esophageal cancer therapy.
@ast
Targeting VEGFR1- and VEGFR2-e ...... for esophageal cancer therapy.
@en
prefLabel
Targeting VEGFR1- and VEGFR2-e ...... for esophageal cancer therapy.
@ast
Targeting VEGFR1- and VEGFR2-e ...... for esophageal cancer therapy.
@en
P2093
P2860
P356
P1433
P1476
Targeting VEGFR1- and VEGFR2-e ...... for esophageal cancer therapy.
@en
P2093
Alfred K Y Lam
Annie L M Cheung
Kwok Wah Chan
Qiu Ju Yuan
Sai Wah Tsao
Simon Y K Law
Wen Wen Xu
P2860
P304
P356
10.18632/ONCOTARGET.2781
P407
P577
2015-01-01T00:00:00Z